USFDA completes inspection at Auro Peptides Ltd's facility with zero observations

The manufacturing unit of Auro Peptides Ltd, the synthetic peptides API business arm of Aurobindo Pharma Ltd, situated at Indrakaran Village, Kandi Mandal, Sangareddy District, Telangana, was audited by the US FDA from 12th to 16th February 2024. The inspection was concluded with zero observations.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1033.75 as compared to the previous close of Rs. 1018.20. The total number of shares traded during the day was 157278 in over 6261 trades.

The stock hit an intraday high of Rs. 1054.00 and intraday low of 1020.25. The net turnover during the day was Rs. 163264258.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 AuroPeptides USFDA Inspection ZeroObservations